The Critical Side Effect Doctors Aren't Discussing: Out-of-Pocket Costs
In this video, I talk about why doctors should talk to patients about out-of-pocket costs when evaluating treatment options.
Similar Posts
Drugs Are Outrageously Expensive—Canada Found A Way To Fight Back
Latuda is a drug to treat schizophrenia. It costs about $4,000 per month in the U.S. In Canada, the price is closer to $500.
Ibrance, a breast cancer drug, costs $10,000 more per month in the U.S. than in Canada.
Why these enormous price differences?
Medicare Savings Might Be Costing Us: Here’s Why
Could ACOs be costing us money?
